Deep sequencing reveals microRNAs predictive of antiangiogenic drug response

Autor: García-Donas J, Beuselinck B, Inglada-Pérez L, Graña O, Schöffski P, Wozniak A, Bechter O, Apellániz-Ruiz M, Lj, Leandro-García, Esteban E, Castellano DE, González Del Alba A, Ma, Climent, Hernando S, Ja, Arranz, Manuel M Morente, Dg, Pisano, Robledo M, Rodriguez-Antona C

Publikováno v: Europe PubMed Central

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::053a36ebaa4a13af0f6a35d9bfdec112
http://europepmc.org/abstract/med/27699216

A Braf kinase-inactive mutant induces lung adenocarcinoma.

Autor: Nieto P; Experimental Oncology, Molecular Oncology Programme, Centro Nacional de Investigaciones Oncológicas (CNIO), 28029 Madrid, Spain., Ambrogio C; Experimental Oncology, Molecular Oncology Programme, Centro Nacional de Investigaciones Oncológicas (CNIO), 28029 Madrid, Spain., Esteban-Burgos L; Experimental Oncology, Molecular Oncology Programme, Centro Nacional de Investigaciones Oncológicas (CNIO), 28029 Madrid, Spain., Gómez-López G; Bioinformatics Unit, Structural Biology and Biocomputing Programme, Centro Nacional de Investigaciones Oncológicas (CNIO), 28029 Madrid, Spain., Blasco MT; Experimental Oncology, Molecular Oncology Programme, Centro Nacional de Investigaciones Oncológicas (CNIO), 28029 Madrid, Spain., Yao Z; Program in Molecular Pharmacology, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA., Marais R; Molecular Oncology Group, Cancer Research UK Manchester Institute, M20 4BX Manchester, UK., Rosen N; Program in Molecular Pharmacology, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA., Chiarle R; Department of Pathology, Harvard Medical School, Boston Children's Hospital, Boston, Massachusetts, USA., Pisano DG; Bioinformatics Unit, Structural Biology and Biocomputing Programme, Centro Nacional de Investigaciones Oncológicas (CNIO), 28029 Madrid, Spain., Barbacid M; Experimental Oncology, Molecular Oncology Programme, Centro Nacional de Investigaciones Oncológicas (CNIO), 28029 Madrid, Spain., Santamaría D; Experimental Oncology, Molecular Oncology Programme, Centro Nacional de Investigaciones Oncológicas (CNIO), 28029 Madrid, Spain.

Publikováno v: Nature [Nature] 2017 Aug 10; Vol. 548 (7666), pp. 239-243. Date of Electronic Publication: 2017 Aug 02.

Prediction of miRNA-mRNA Interactions Using miRGate.

Autor: Andrés-León E; Bioinformatics Unit, Instituto de Parasitología y Biomedicina 'López Neyra', Consejo Superior de Investigaciones Científicas (IPBLN-CSIC), PTS Granada, Granada, 18016, Spain. eduardo.andres@csic.es., Gómez-López G; Bioinformatics Unit (UBio), Structural Biology and Biocomputing Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain., Pisano DG; Bioinformatics Unit (UBio), Structural Biology and Biocomputing Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.

Publikováno v: Methods in molecular biology (Clifton, N.J.) [Methods Mol Biol] 2017; Vol. 1580, pp. 225-237.

Erratum to: The UBC-40 Urothelial Bladder Cancer cell line index: a genomic resource for functional studies.

Autor: Earl J; Epithelial Carcinogenesis Group, F BBVA Cancer Cell Biology Programme, CNIO (Spanish National Cancer Research Centre), Madrid, Spain.; Servicio de Oncología Médica, Hospital Ramón y Cajal, Madrid, Spain., Rico D; Structural Computational Biology Group, Structural Biology and Biocomputing Programme, CNIO (Spanish National Cancer Research Centre), Madrid, Spain., Carrillo-de-Santa-Pau E; Epithelial Carcinogenesis Group, F BBVA Cancer Cell Biology Programme, CNIO (Spanish National Cancer Research Centre), Madrid, Spain., Rodríguez-Santiago B; Quantitative Genomic Medicine Laboratory, qGenomics, Barcelona, Spain.; Departament de Ciències Experimentals i de la Salut, Universitat Pompeu Fabra, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Barcelona, Spain., Méndez-Pertuz M; Epithelial Carcinogenesis Group, F BBVA Cancer Cell Biology Programme, CNIO (Spanish National Cancer Research Centre), Madrid, Spain., Auer H; Institut de Recerca Biomèdica de Barcelona, Parc Científic de Barcelona, Barcelona, Spain., Gómez G; Bioinformatics Unit, Structural Biology and Biocomputing Programme, CNIO (Spanish National Cancer Research Centre), Madrid, Spain., Grossman HB; Department of Urology, MD Anderson Cancer Center, Houston, TX, USA., Pisano DG; Bioinformatics Unit, Structural Biology and Biocomputing Programme, CNIO (Spanish National Cancer Research Centre), Madrid, Spain., Schulz WA; Department of Urology, Heinrich-Heine-University, Düsseldorf, Germany., Pérez-Jurado LA; Departament de Ciències Experimentals i de la Salut, Universitat Pompeu Fabra, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Barcelona, Spain., Carrato A; Servicio de Oncología Médica, Hospital Ramón y Cajal, Madrid, Spain., Theodorescu D; University of Colorado Comprehensive Cancer Center, Aurora, CO, 80045, USA., Chanock S; Translational Genomics Laboratory, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, USA., Valencia A; Structural Computational Biology Group, Structural Biology and Biocomputing Programme, CNIO (Spanish National Cancer Research Centre), Madrid, Spain., Real FX; Epithelial Carcinogenesis Group, F BBVA Cancer Cell Biology Programme, CNIO (Spanish National Cancer Research Centre), Madrid, Spain. preal@cnio.es.; Departament de Ciències Experimentals i de la Salut, Universitat Pompeu Fabra, Barcelona, Spain. preal@cnio.es.

Publikováno v: BMC genomics [BMC Genomics] 2016 Oct 25; Vol. 17 (1), pp. 829. Date of Electronic Publication: 2016 Oct 25.

Somatic Embryonic FGFR2 Mutations in Keratinocytic Epidermal Nevi.

Autor: Toll A; Department of Dermatology, Parc de Salut Mar, Hospital del Mar, Barcelona, Spain., Fernández LC; Epithelial Carcinogenesis Group, Cancer Cell Biology Programme, CNIO (Spanish National Cancer Research Centre), Madrid, Spain., Pons T; Structural Computational Biology Group, Structural Biology and Biocomputing Programme, CNIO (Spanish National Cancer Research Centre), Madrid, Spain., Groesser L; Department of Dermatology, University of Regensburg, Regensburg, Germany., Sagrera A; Epithelial Carcinogenesis Group, Cancer Cell Biology Programme, CNIO (Spanish National Cancer Research Centre), Madrid, Spain., Carrillo-de Santa Pau E; Epithelial Carcinogenesis Group, Cancer Cell Biology Programme, CNIO (Spanish National Cancer Research Centre), Madrid, Spain., Vicente A; Department of Dermatology, Hospital Sant Joan de Déu, University of Barcelona, Esplugues, Spain., Baselga E; Department of Dermatology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain., Vázquez M; Structural Computational Biology Group, Structural Biology and Biocomputing Programme, CNIO (Spanish National Cancer Research Centre), Madrid, Spain., Beltrán S; Centro Nacional de Análisis Genómico (CNAG), Barcelona, Spain., Pisano DG; Bioinformatics Unit, Structural Biology and Biocomputing Programme, CNIO (Spanish National Cancer Research Centre), Madrid, Spain., Rueda D; Hereditary Cancer Genetic Diagnostic Laboratory, Biochemistry Department, Doce de Octubre University Hospital, Madrid, Spain., Gut M; Centro Nacional de Análisis Genómico (CNAG), Barcelona, Spain., Pujol RM; Department of Dermatology, Parc de Salut Mar, Hospital del Mar, Barcelona, Spain., Hafner C; Department of Dermatology, University of Regensburg, Regensburg, Germany., Gut I; Centro Nacional de Análisis Genómico (CNAG), Barcelona, Spain., Valencia A; Structural Computational Biology Group, Structural Biology and Biocomputing Programme, CNIO (Spanish National Cancer Research Centre), Madrid, Spain., Real FX; Department of Dermatology, Parc de Salut Mar, Hospital del Mar, Barcelona, Spain; Departament de Ciències Experimentals i de la Salut, Universitat Pompeu Fabra, Barcelona, Spain. Electronic address: preal@cnio.es.

Publikováno v: The Journal of investigative dermatology [J Invest Dermatol] 2016 Aug; Vol. 136 (8), pp. 1718-1721. Date of Electronic Publication: 2016 Apr 19.